Evotec SE (EVO) Non-Current Deferred Tax Liability (2009 - 2026)

Evotec SE (EVO) reported Non-Current Deferred Tax Liability of $14831.0 for Q1 2026, up 4.13% on a YoY basis from $14242.5 in Q1 2025, and down 13.53% sequentially from $17152.2 in Q4 2025.

Evotec SE (EVO) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends

Evotec SE (EVO) has 9 years of Non-Current Deferred Tax Liability data on file, last reported at $14831.0 in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 4.13% year-over-year to $14831.0; the trailing twelve-month figure through Mar 2026 stood at $14831.0 (up 4.13% YoY), and the FY2025 full-year result was $17152.2, down 99.89% from the prior year.
  • Non-Current Deferred Tax Liability slipped to $14831.0 in Q1 2026, from $17152.2 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $68.8 million in Q4 2022 to a low of $14242.5 in Q1 2025.
  • A 5-year average of $9.4 million and a median of $17152.2 in 2025 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 239.9% in 2022 and tumbled 99.89% in 2025, its largest moves.
  • Tracing EVO's Non-Current Deferred Tax Liability over 5 years: stood at $68.8 million in 2022, then plunged by 71.63% to $19.5 million in 2023, then dropped by 20.51% to $15.5 million in 2024, then plunged by 99.89% to $17152.2 in 2025, then decreased by 13.53% to $14831.0 in 2026.
  • Business Quant data shows EVO's Non-Current Deferred Tax Liability at $14831.0 in Q1 2026, $17152.2 in Q4 2025, and $15947.1 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.78 Bn 87.91 Bn -
2 Teva Pharmaceutical Industries 35.91 Bn 32.17 Bn 1.97 Bn
3 Zoetis 32.59 Bn 30.65 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn
5 United Therapeutics 23.04 Bn 20.89 Bn 648.10 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn -
7 Viatris 20.40 Bn 18.60 Bn 1.16 Bn
8 Neurocrine Biosciences 17.80 Bn 16.49 Bn 800.70 Mn
9 Elanco Animal Health 12.60 Bn 12.17 Bn 785.00 Mn
10 Evotec SE 345.21 Mn 344.69 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 14,831.01
Mar 31, 2026 14,831.01
Dec 31, 2025 17,152.18
Dec 31, 2025 17,152.18
Sep 30, 2025 15,947.08
Sep 30, 2025 15,947.08
Jun 30, 2025 15,513.51
Jun 30, 2025 15,513.51
Mar 31, 2025 14,242.52
Mar 31, 2025 14,242.52
Dec 31, 2024 15.51 Mn
Dec 31, 2024 15.51 Mn
Sep 30, 2024 15,432.18
Sep 30, 2024 15,432.18
Dec 31, 2023 19.51 Mn
Dec 31, 2023 19.51 Mn
Dec 31, 2022 68.78 Mn
Dec 31, 2022 68.78 Mn
Sep 30, 2022 17,321.14
Sep 30, 2022 17,321.14